C. Elliott

发表

2017 NIA-AA RESEARCH FRAMEWORK TO INVESTIGATE THE ALZHEIMER’S DISEASE CONTINUUM

D. Holtzman, C. Jack, D. Bennett, 2017, Alzheimer's & Dementia.

2018 NIA-AA Research Framework to Investigate the Alzheimer ’ s Disease Continuum 1 2 DRAFT 7-18-17 3 4 5 Clifford

D. Holtzman, D. Bennett, W. Jagust, 2017 .

omers can disrupt normal neuronal homeostasis by triggering focal accumulation of axonal tau, loss of the polarized distribution of tau and dysregulation of fast axonal transport

D. Holtzman, D. Bennett, T. Montine, 2017 .

DIVISION OF NEUROSCIENCE

C. Elliott, 2018, Innovation in Aging.

Including ethnic minorities in dementia research: Recommendations from a scoping review

A. Lampit, C. Elliott, Antonia Thodis, 2022, Alzheimer's & dementia.

NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer’s disease

E. Masliah, C. Elliott, Laurie M. Ryan, 2018, Alzheimer's & Dementia.

Together We Make the Difference: National Strategy for Recruitment and Participation in Alzheimer's and Related Dementias Clinical Research.

C. Elliott, 2020, Ethnicity & disease.

Building Inclusive and Open Alzheimer Disease and Alzheimer Disease-Related Dementias Research Programs.

C. Elliott, Laurie M. Ryan, N. Silverberg, 2021, JAMA neurology.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

Raymond Scott Turner, Susie A. Sami, David M. Shade, 2018, Trials.

Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5

C. Jack, D. Bennett, T. Montine, 2017 .